AC
Armistice Capital Portfolio holdings
AUM
$2.64B
This Quarter Return
+0.24%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$3.98B
AUM Growth
+$3.98B
(-7.4%)
Cap. Flow
-$339M
Cap. Flow
% of AUM
-8.5%
Top 10 Holdings %
Top 10 Hldgs %
28.71%
Holding
293
New
68
Increased
45
Reduced
98
Closed
73
Top Buys
| 1 |
Pfizer
PFE
|
$76.9M |
| 2 |
NVRO
NEVRO CORP.
NVRO
|
$59.9M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
$56.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$51.7M |
| 5 |
Keurig Dr Pepper
KDP
|
$42.1M |
Top Sells
| 1 |
GSK
GSK
|
$105M |
| 2 |
Exact Sciences
EXAS
|
$83M |
| 3 |
Organon & Co
OGN
|
$75.3M |
| 4 |
Biogen
BIIB
|
$55.3M |
| 5 |
Central Garden & Pet Class A
CENTA
|
$53.3M |
Sector Composition
| 1 | Healthcare | 68.27% |
| 2 | Consumer Staples | 10.31% |
| 3 | Technology | 7.85% |
| 4 | Consumer Discretionary | 7.66% |
| 5 | Communication Services | 3.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
26
DELISTED
Paramount Global Class B
PARA
| $44.4M | 0.64% |
2,788,000
+724,000
| +35% | +$11.5M |
|
|
27
Exact Sciences
EXAS
$9.17B
| $44.3M | 0.64% |
472,000
-884,000
| -65% | -$83M |
|
28
Post Holdings
POST
$6.02B
| $44.1M | 0.64% |
508,410
| – | – |
|
29
Orthofix Medical
OFIX
$573M
| $44M | 0.64% |
2,436,000
+600,000
| +33% | +$10.8M |
|
30
Novo Nordisk
NVO
$253B
| $43.7M | 0.63% |
270,000
-22,000
| -8% | -$3.56M |
|
31
Vertex Pharmaceuticals
VRTX
$101B
| $43.6M | 0.63% |
124,000
-96,000
| -44% | -$33.8M |
|
32
Enanta Pharmaceuticals
ENTA
$190M
| $43.6M | 0.63% |
2,036,000
+24,000
| +1% | +$514K |
|
33
Biohaven
BHVN
$1.67B
| $43.1M | 0.62% |
1,800,000
-1,324,000
| -42% | -$31.7M |
|
|
SWAV
34
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $42.8M | 0.62% |
150,000
-106,000
| -41% | -$30.3M |
|
|
35
Keurig Dr Pepper
KDP
$39B
| $42.1M | 0.61% |
+1,347,000
| New | +$42.1M |
|
36
Voyager Therapeutics
VYGR
$210M
| $41.5M | 0.6% |
3,624,000
+100,000
| +3% | +$1.15M |
|
37
Campbell Soup
CPB
$9.86B
| $35.7M | 0.52% |
+780,000
| New | +$35.7M |
|
|
EVBG
38
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $32.3M | 0.47% |
1,200,000
+350,000
| +41% | +$9.42M |
|
39
Procter & Gamble
PG
$368B
| $31.9M | 0.46% |
210,000
+206,361
| +5,671% | +$31.3M |
|
40
SentinelOne
S
$5.99B
| $31.6M | 0.46% |
2,096,000
+1,560,000
| +291% | +$23.6M |
|
41
Madrigal Pharmaceuticals
MDGL
$9.49B
| $31.4M | 0.45% |
136,000
-140,000
| -51% | -$32.3M |
|
42
Energizer
ENR
$1.92B
| $31.2M | 0.45% |
930,000
+370,000
| +66% | +$12.4M |
|
43
DocuSign
DOCU
$15.4B
| $30.2M | 0.44% |
592,000
+68,000
| +13% | +$3.47M |
|
44
Kraft Heinz
KHC
$31.5B
| $30.2M | 0.44% |
850,000
| – | – |
|
45
MacroGenics
MGNX
$118M
| $30M | 0.43% |
5,600,000
-360,000
| -6% | -$1.93M |
|
46
CareDx
CDNA
$689M
| $28.3M | 0.41% |
3,324,000
+188,000
| +6% | +$1.6M |
|
47
CRISPR Therapeutics
CRSP
$4.81B
| $28.1M | 0.41% |
500,000
-324,000
| -39% | -$18.2M |
|
48
Intuitive Surgical
ISRG
$158B
| $28M | 0.41% |
82,000
-126,000
| -61% | -$43.1M |
|
49
Immunocore
IMCR
$1.73B
| $25.7M | 0.37% |
428,000
+50,000
| +13% | +$3M |
|
50
Bristol-Myers Squibb
BMY
$96.8B
| $25.6M | 0.37% |
+400,000
| New | +$25.6M |
|